More than three years after it envisaged the need for an action plan to keep pace with ongoing scientific and technological advances, the European Medicines Agency says it now has a pretty clear idea of the key areas it needs to focus on over the next five years.
These areas, to be incorporated in the agency’s “Regulatory Science to 2025” strategy, are fostering innovation in clinical trials, promoting...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?